electroCore (NASDAQ:ECOR) Upgraded by Brookline Cap M to Strong-Buy Rating

Brookline Cap M upgraded shares of electroCore (NASDAQ:ECORFree Report) to a strong-buy rating in a report issued on Tuesday morning,Zacks.com reports. Brookline Cap M also issued estimates for electroCore’s Q4 2025 earnings at ($0.39) EPS, FY2025 earnings at ($1.70) EPS, Q1 2026 earnings at ($0.33) EPS, Q2 2026 earnings at ($0.12) EPS, Q3 2026 earnings at ($0.08) EPS, Q4 2026 earnings at ($0.01) EPS and FY2026 earnings at ($0.53) EPS.

Several other brokerages have also commented on ECOR. Brookline Capital Acquisition raised electroCore to a “strong-buy” rating in a research note on Tuesday. HC Wainwright cut their price objective on electroCore from $25.00 to $18.00 and set a “buy” rating for the company in a report on Monday, January 26th. Wall Street Zen upgraded shares of electroCore from a “sell” rating to a “hold” rating in a research note on Saturday, November 8th. Zacks Research downgraded shares of electroCore from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of electroCore in a research note on Monday, December 29th. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $22.00.

View Our Latest Stock Analysis on electroCore

electroCore Price Performance

Shares of electroCore stock traded up $0.38 during trading on Tuesday, hitting $5.45. 25,990 shares of the company’s stock traded hands, compared to its average volume of 85,068. The company has a market cap of $43.60 million, a PE ratio of -3.19 and a beta of 0.48. The firm’s fifty day moving average price is $5.58 and its 200 day moving average price is $5.44. electroCore has a twelve month low of $4.16 and a twelve month high of $19.49.

electroCore (NASDAQ:ECORGet Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.07). electroCore had a negative return on equity of 447.87% and a negative net margin of 47.46%.The business had revenue of $8.69 million for the quarter, compared to the consensus estimate of $7.84 million. As a group, equities research analysts anticipate that electroCore will post -1.49 earnings per share for the current year.

Hedge Funds Weigh In On electroCore

Large investors have recently modified their holdings of the stock. NewEdge Advisors LLC increased its holdings in shares of electroCore by 857.9% in the first quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock valued at $1,083,000 after purchasing an additional 145,047 shares in the last quarter. Tejara Capital Ltd bought a new position in electroCore in the 4th quarter valued at $450,000. International Assets Investment Management LLC increased its stake in shares of electroCore by 65.7% in the 2nd quarter. International Assets Investment Management LLC now owns 77,020 shares of the company’s stock valued at $407,000 after buying an additional 30,550 shares during the period. Cubist Systematic Strategies LLC bought a new stake in shares of electroCore during the first quarter worth $153,000. Finally, Jane Street Group LLC lifted its stake in shares of electroCore by 114.4% during the first quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after acquiring an additional 19,599 shares during the period. 26.74% of the stock is currently owned by institutional investors and hedge funds.

electroCore News Summary

Here are the key news stories impacting electroCore this week:

  • Positive Sentiment: Brookline Capital Management upgraded ECOR to a “Strong-Buy” and published new estimates that point toward improving profitability — forecasting FY2026 EPS of ($0.53) and a near-breakeven Q4 2026 EPS of ($0.01), which investors may view as a catalyst for the stock. Zacks Upgrade
  • Neutral Sentiment: Brookline released a detailed quarter-by-quarter EPS schedule (Q4 2025: ($0.39); Q1 2026: ($0.33); Q2 2026: ($0.12); Q3 2026: ($0.08); Q4 2026: ($0.01)) giving investors a roadmap for when improvement is expected, but these are analyst projections rather than company guidance. MarketBeat Estimates
  • Negative Sentiment: Despite the upgrade, Brookline still models a sizable loss for FY2025 (forecast: ($1.70) EPS), which is worse than the current consensus full-year estimate of ($1.49) — a reminder that near-term profitability and cash flow remain risk factors. MarketBeat Estimates

electroCore Company Profile

(Get Free Report)

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.

Read More

Analyst Recommendations for electroCore (NASDAQ:ECOR)

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.